Comprehensive physiology · 2022 · 124 citations · 209 references
Life SciencesBiochemistryPhysiologyGlycobiologyMechanobiologySignal TransductionCell-surface GlycansEndothelial ActivationGlycan StructureLeukocyte TraffickingMechanotransductionVascular PermeabilityBlood Flow Under ShearEndothelial Glycocalyx FunctionFlow-mediated VasodilationGlycocalyx ArchitectureGlycocalyx MechanobiologyGlycocalyx StructureHeparan Sulfate ProteoglycansNitric Oxide-mediated Vasodilation
The glycocalyx is a polysaccharide structure that protrudes from the body of a cell. It is primarily conformed of glycoproteins and proteoglycans, which provide communication, electrostatic charge, ionic buffering, permeability, and mechanosensation-mechanotransduction capabilities to cells. In blood vessels, the endothelial glycocalyx that projects into the vascular lumen separates the vascular wall from the circulating blood. Such a physical location allows a number of its components, including sialic acid, glypican-1, heparan sulfate, and hyaluronan, to participate in the mechanosensation-mechanotransduction of blood flow-dependent shear stress, which results in the synthesis of nitric oxide and flow-mediated vasodilation. The endothelial glycocalyx also participates in the regulation of vascular permeability and the modulation of inflammatory responses, including the processes of leukocyte rolling and extravasation. Its structural architecture and negative charge work to prevent macromolecules greater than approximately 70 kDa and cationic molecules from binding and flowing out of the vasculature. This also prevents the extravasation of pathogens such as bacteria and virus, as well as that of tumor cells. Due to its constant exposure to shear and circulating enzymes such as neuraminidase, heparanase, hyaluronidase, and matrix metalloproteinases, the endothelial glycocalyx is in a continuous process of degradation and renovation. A balance favoring degradation is associated with a variety of pathologies including atherosclerosis, hypertension, vascular aging, metastatic cancer, and diabetic vasculopathies. Consequently, ongoing research efforts are focused on deciphering the mechanisms that promote glycocalyx degradation or limit its syntheses, as well as on therapeutic approaches to improve glycocalyx integrity with the goal of reducing vascular disease. © 2022 American Physiological Society. Compr Physiol 12: 1-31, 2022.
209
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
G. Ya. Wiederschain · Biochemistry (Moscow) · 2009 · 4.1K citations · Full text
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar et al. · Hypertension · 2020 · 4.1K citations · Full text
Pericytes regulate the blood–brain barrier
Annika Armulik, Guillem Genové, Maarja Andaloussi Mäe et al. · Nature · 2010 · 2.8K citations · Full text